Torthaí cuardaigh - Burton, Barbara
- 1 - 20 toradh as 54 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
-
2
Diagnosis and Clinical Management of Long-chain Fatty-acid Oxidation Disorders: A Review de réir Baker, Joshua J, Burton, Barbara K
Foilsithe / Cruthaithe 2021Téacs -
3
Newborn Screening for Mucopolysaccharidosis Type II in Illinois: An Update de réir Burton, Barbara K., Hickey, Rachel, Hitchins, Lauren
Foilsithe / Cruthaithe 2020Téacs -
4
Congenital scalp defects with distal limb anomalies: Report of a family de réir Burton, Barbara K., Hauser, Lynn, Nadler, Henry L.
Foilsithe / Cruthaithe 1976Téacs -
5
Successful reduction of high-sustained anti-idursulfase antibody titers by immune modulation therapy in a patient with severe mucopolysaccharidosis type II de réir Kim, Katherine H., Messinger, Yoav H., Burton, Barbara K.
Foilsithe / Cruthaithe 2014Téacs -
6
Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder de réir Wijburg, Frits A, Węgrzyn, Grzegorz, Burton, Barbara K, Tylki-Szymańska, Anna
Foilsithe / Cruthaithe 2013Téacs -
7
Evaluation of the long-term treatment effects of intravenous idursulfase in patients with mucopolysaccharidosis II (MPS II) using statistical modeling: data from the Hunter Outcome... de réir Muenzer, Joseph, Botha, Jaco, Harmatz, Paul, Giugliani, Roberto, Kampmann, Christoph, Burton, Barbara K.
Foilsithe / Cruthaithe 2021Téacs -
8
-
9
Newborn Screening for X-Linked Adrenoleukodystrophy: The Initial Illinois Experience de réir Burton, Barbara K., Hickey, Rachel, Hitchins, Lauren, Shively, Vera, Ehrhardt, Joan, Ashbaugh, Laura, Peng, Yin, Basheeruddin, Khaja
Foilsithe / Cruthaithe 2022Téacs -
10
Mutation in BAG3 Causes Severe Dominant Childhood Muscular Dystrophy de réir Selcen, Duygu, Muntoni, Francesco, Burton, Barbara K., MD, Elena Pegoraro, Sewry, Caroline, Bite, Anna V., Engel, Andrew G.
Foilsithe / Cruthaithe 2009Téacs -
11
N-carbamylglutamate Markedly Enhances Ureagenesis in N-acetylglutamate Deficiency and Propionic Acidemia as Measured by Isotopic Incorporation and Blood Biomarkers de réir Tuchman, Mendel, Caldovic, Ljubica, Daikhin, Yevgeny, Horyn, Oksana, Nissim, Ilana, Nissim, Itzhak, Korson, Mark, Burton, Barbara, Yudkoff, Marc
Foilsithe / Cruthaithe 2008Téacs -
12
Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria de réir Zori, Roberto, Ahring, Kirsten, Burton, Barbara, Pastores, Gregory M., Rutsch, Frank, Jha, Ashok, Jurecki, Elaina, Rowell, Richard, Harding, Cary
Foilsithe / Cruthaithe 2019Téacs -
13
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome de réir Hendriksz, Christian J., Muenzer, Joseph, Burton, Barbara K., Pan, Luying, Wang, Nan, Naimy, Hicham, Pano, Arian, Barbier, Ann J.
Foilsithe / Cruthaithe 2019Online -
14
Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II de réir Herbst, Zackary M., Urdaneta, Leslie, Klein, Terri, Burton, Barbara K., Basheeruddin, Khaja, Liao, Hsuan-Chieh, Fuller, Maria, Gelb, Michael H.
Foilsithe / Cruthaithe 2022Téacs -
15
Long-term experience with enzyme replacement therapy (ERT) in MPS II patients with a severe phenotype: an international case series de réir Lampe, Christina, Bosserhoff, Ann-Kathrin, Burton, Barbara K., Giugliani, Roberto, de Souza, Carolina F., Bittar, Camila, Muschol, Nicole, Olson, Rebecca, Mendelsohn, Nancy J.
Foilsithe / Cruthaithe 2014Téacs -
16
The role of enzyme replacement therapy in severe Hunter syndrome—an expert panel consensus de réir Muenzer, Joseph, Bodamer, Olaf, Burton, Barbara, Clarke, Lorne, Frenking, Gudrun Schulze, Giugliani, Roberto, Jones, Simon, Rojas, Maria Verónica Muñoz, Scarpa, Maurizio, Beck, Michael, Harmatz, Paul
Foilsithe / Cruthaithe 2011Téacs -
17
Phase 1 Trial of Subcutaneous rAvPAL-PEG in Subjects with Phenylketonuria de réir Longo, Nicola, Harding, Cary O., Burton, Barbara K., Grange, Dorothy K., Vockley, Jerry, Wasserstein, Melissa, Rice, Gregory M., Musson, Donald G., Gu, Zhonghua, Sile, Saba
Foilsithe / Cruthaithe 2014Téacs -
18
Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment de réir Hendriksz, Christian J., Muenzer, Joseph, Vanderver, Adeline, Davis, Jonathan M., Burton, Barbara K., Mendelsohn, Nancy J., Wang, Nan, Pan, Luying, Pano, Arian, Barbier, Ann J.
Foilsithe / Cruthaithe 2015Téacs -
19
Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study de réir Longo, Nicola, Zori, Roberto, Wasserstein, Melissa P., Vockley, Jerry, Burton, Barbara K., Decker, Celeste, Li, Mingjin, Lau, Kelly, Jiang, Joy, Larimore, Kevin, Thomas, Janet A.
Foilsithe / Cruthaithe 2018Téacs -
20
Effects of triheptanoin (UX007) in patients with long‐chain fatty acid oxidation disorders: Results from an open‐label, long‐term extension study de réir Vockley, Jerry, Burton, Barbara, Berry, Gerard, Longo, Nicola, Phillips, John, Sanchez‐Valle, Amarilis, Chapman, Kimberly, Tanpaiboon, Pranoot, Grunewald, Stephanie, Murphy, Elaine, Lu, Xiaoxiao, Cataldo, Jason
Foilsithe / Cruthaithe 2020Téacs